{"pub_date": "2016-01-21T00:00:00Z", "subsection_name": null, "lead_paragraph": "In a declaration to be released at the World Economic Forum, more than 80 companies say government help and better reimbursement is needed to fight the problem of drug-resistant germs.", "print_page": "2", "document_type": "article", "byline": {"person": [{"rank": 1, "organization": "", "lastname": "POLLACK", "firstname": "Andrew", "role": "reported"}], "original": "By ANDREW POLLACK"}, "multimedia": [], "section_name": "Business Day", "headline": {"print_headline": "Business Briefing; Health Firms Call for Incentives to Develop \u2018Superbug\u2019 Drugs", "main": "To Fight \u2018Superbugs,\u2019 Drug Makers Call for Incentives to Develop Antibiotics"}, "source": "The New York Times", "blog": [], "word_count": "593", "web_url": "http://www.nytimes.com/2016/01/21/business/to-fight-superbugs-drug-makers-call-for-incentives-to-develop-antibiotics.html", "slideshow_credits": null, "news_desk": "Business", "type_of_material": "News", "snippet": "In a declaration to be released at the World Economic Forum, more than 80 companies say government help and better reimbursement is needed to fight the problem of drug-resistant germs.", "_id": "56a0200238f0d80627b20b7f", "abstract": "Over 80 pharmaceutical and diagnostic companies plan to release declaration at World Economic Forum in Davos, Switzerland, calling for new economic models to encourage development of new antibiotics and to combat global threat of drug-resistant bacteria.", "keywords": [{"rank": "1", "name": "subject", "value": "Antibiotics", "is_major": "Y"}, {"rank": "2", "name": "organizations", "value": "World Economic Forum", "is_major": "Y"}, {"rank": "3", "name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "N"}]}